Twist Bioscience at the European Symposium of Human Genetics 2025.
We're excited to be part of the ESHG 2025, and we can't wait to connect with you in beautiful Milan! This year's conference promises to be an incredible gathering of innovative minds in genomics, and Twist Bioscience is proud to be at the forefront of groundbreaking scientific exploration.
ESHG Quick Guide
Dates
May 24-26, 2025 Learn More
Milan, Italy
Allianz MiCo, Milan Get directions
Twist Booth Location
Booth #472 View floormap
What to Expect from Twist Bioscience
Join us at Booth #472 and let’s discuss how Twist Bioscience can empower your genetics and genomics research.
Our experts will be on hand to explore your projects and guide you through a wide range of solutions based on your sample types: FFPE, cfDNA, ctDNA, or RNAseq, and experimental goals. Discover our high-quality exome solutions; let us guide you through IVDR compliance; or learn about our enrichment solutions.
Stop by, have a conversation, drink a coffee with us, and don’t forget to grab your exclusive Twist Bioscience socks.
We look forward to seeing you at Booth #472!
Join us at ESHG 2025
Corporate Satellite Event: Unleash the Power of Your Samples: Next-Level Sequencing with Twist Bioscience.
May 26, 12 - 13 CEST
Room Amber 5+6
Discover how cutting-edge sequencing technologies are empowering researchers to achieve unprecedented results. Learn how labs are leveraging Twist Bioscience solutions to tackle complex challenges across a wide spectrum of research areas. From unraveling understanding of complex cancer genomes to advancing molecular diagnostics, we invite you to explore the future of genomics.
Learn how Twist technologies can revolutionize your lab.
Unleash the Power of Your Samples: Next-Level Sequencing with Twist Bioscience
- Yann Merlet, Senior NGS Field Application Scientist at Twist Bioscience, Europe
Learn how Twist's cutting-edge solutions can revolutionize your lab's capabilities with its latest innovations in agnostic sequencing solutions, demonstrating how their technologies are empowering researchers to achieve unprecedented results across diverse research areas, including complex cancer genomics and advanced molecular diagnostics.
An innovative approach for detecting cancer-associated germline variants using a multiplexed targeted HiFi read sequencing workflow
- Mayra Sauer, PhD - Co-Lead Research and Development - MGZ München, Germany
The group from Mayra Sauer, PhD, developed a long-read targeted sequencing workflow for 175 key HTS-associated genes (14 Mb target), covering twelve common tumor types on the Hereditary tumor syndromes (HTS). This optimized long-read whole gene body sequencing workflow is developed with a collaboration with Twist Bioscience, PacBio, Beckman, and EnGenome.
Clinical implementation of ctDNA NGS testing for cancer patient management
- Julie Vendrell, PhD - Research Scientist in the Solid Tumor Biology Lab - CHU Montpellier, Université de Montpellier, France
The laboratory of Julie Vendrell, PhD implemented a UMI-based ctDNA NGS analysis using a custom panel with an open-source pipeline, MobiCT, developed to accurately detect genetic variants in ctDNA samples without the need for normal controls or matched germline sequencing, with a strong capability to balance sensitivity and specificity according to the requirements of clinical applications.
POSTERS
Utilization of Twist CNV Backbone Spike-in Panel with exome for cytogenetic research
- Presented by Twist Bioscience
Evaluation of Twist CNV Backbone Spike-in Panels at different probe densities and samples coverage for large pathological CNV detection
- Twist Bioscience is co-authoring with enGenome being the lead author
Not attending ESHG 25 this year?
Check out our latest innovations and resources:
